Cipher Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 29.99

CPH Stock  CAD 14.01  0.86  5.78%   
Cipher Pharmaceuticals' future price is the expected price of Cipher Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cipher Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Cipher Pharmaceuticals Backtesting, Cipher Pharmaceuticals Valuation, Cipher Pharmaceuticals Correlation, Cipher Pharmaceuticals Hype Analysis, Cipher Pharmaceuticals Volatility, Cipher Pharmaceuticals History as well as Cipher Pharmaceuticals Performance.
  
Please specify Cipher Pharmaceuticals' target price for which you would like Cipher Pharmaceuticals odds to be computed.

Cipher Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cipher Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cipher Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cipher Pharmaceuticals generated a negative expected return over the last 90 days
Cipher Pharmaceuticals has high historical volatility and very poor performance
The company has C$353,000 in debt which may indicate that it relies heavily on debt financing
About 42.0% of the company shares are held by company insiders

Cipher Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cipher Stock often depends not only on the future outlook of the current and potential Cipher Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cipher Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding25.4 M
Cash And Short Term Investments39.8 M

Cipher Pharmaceuticals Technical Analysis

Cipher Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Cipher Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cipher Pharmaceuticals. In general, you should focus on analyzing Cipher Stock price patterns and their correlations with different microeconomic environments and drivers.

Cipher Pharmaceuticals Predictive Forecast Models

Cipher Pharmaceuticals' time-series forecasting models is one of many Cipher Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cipher Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cipher Pharmaceuticals

Checking the ongoing alerts about Cipher Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cipher Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cipher Pharmaceuticals generated a negative expected return over the last 90 days
Cipher Pharmaceuticals has high historical volatility and very poor performance
The company has C$353,000 in debt which may indicate that it relies heavily on debt financing
About 42.0% of the company shares are held by company insiders

Other Information on Investing in Cipher Stock

Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.